BIO-key International Reports 33% Revenue Growth to $2.15 Million in Q1 2026

BIO-key International, Inc. reported its financial results for the first quarter of 2026, revealing a total revenue of $2.15 million, a 33% increase from $1.61 million in the same period last year. The growth was primarily driven by a 24% rise in license fees, which reached $1.37 million, and a significant 125% increase in hardware sales, totaling $531,256. However, service revenues declined by 9% to $248,384, attributed to the timing of service agreement renewals. The company’s gross profit for the quarter was $1.77 million, compared to $1.33 million in the prior year, reflecting improved operational efficiency.

In terms of expenses, BIO-key reported total costs of $376,300, up 35% from $279,498 in the previous year. The increase was largely due to a rise in hardware costs, which surged to $323,538, influenced by higher sales volumes. Operating expenses decreased slightly to $1.93 million from $1.97 million, with selling, general, and administrative expenses falling by 5% to $1.31 million. The company recorded an operating loss of $157,713, a significant improvement from a loss of $640,638 in the first quarter of 2025.

The company’s balance sheet as of March 31, 2026, showed total assets of $8.16 million, a decrease from $8.30 million at the end of 2025. Cash and cash equivalents were reported at $2.25 million, down from $2.69 million. Total liabilities increased slightly to $3.26 million, with current liabilities rising due to an increase in deferred revenue, which reached approximately $900,500. The company’s stockholders’ equity decreased to $4.89 million, primarily due to a net loss of $205,037 for the quarter.

Strategically, BIO-key continues to focus on expanding its identity access management solutions, particularly in government services and highly regulated industries such as financial services and healthcare. The company is also pursuing strategic acquisitions to enhance its market position. Notably, the company has been working to mitigate losses by reducing marketing and research expenditures and is exploring new markets for its inventory, particularly in Nigeria.

Looking ahead, BIO-key acknowledges the challenges it faces, including a history of losses and the need for additional financing to sustain operations. The company requires approximately $750,000 per month to operate, a target it has struggled to meet consistently through revenue generation. Management has indicated that if revenue does not improve, it may need to seek further financing or make additional operational cuts. The company remains committed to enhancing its product offerings and expanding its customer base to drive future growth.